Royce & Associates LP Stevanato Group S.P.A. Transaction History
Royce & Associates LP
- $10.5 Billion
- Q3 2024
A detailed history of Royce & Associates LP transactions in Stevanato Group S.P.A. stock. As of the latest transaction made, Royce & Associates LP holds 343,159 shares of STVN stock, worth $7.21 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
343,159
Previous 235,290
45.85%
Holding current value
$7.21 Million
Previous $4.32 Million
59.05%
% of portfolio
0.07%
Previous 0.04%
Shares
12 transactions
Others Institutions Holding STVN
# of Institutions
133Shares Held
54.8MCall Options Held
2.7KPut Options Held
1K-
Conestoga Capital Advisors, LLC7.68MShares$161 Million2.13% of portfolio
-
Neuberger Berman Group LLC New York, NY4.56MShares$95.8 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.74MShares$78.6 Million0.05% of portfolio
-
Thrivent Financial For Lutherans Minneapolis, MN2.78MShares$58.5 Million0.11% of portfolio
-
Wellington Management Group LLP Boston, MA2.69MShares$56.6 Million0.01% of portfolio
About Stevanato Group S.p.A.
- Ticker STVN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 264,700,000
- Market Cap $5.56B
- Description
- Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...